 | • レポートコード：GIR-107A12463 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、メルファランのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メルファランの種類別市場規模（2mg錠、5mg錠、50mg注射）、用途別市場規模（多発性骨髄腫、卵巣がん、ALアミロイドーシス、悪性黒色腫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・メルファランの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline、Celon Laboratories、Natco Pharma、Emcure Pharmaceuticals、GLS Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：2mg錠、5mg錠、50mg注射 ・用途別分析2016年-2026年：多発性骨髄腫、卵巣がん、ALアミロイドーシス、悪性黒色腫、その他 ・メルファランの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・メルファランのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・メルファランのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・メルファランの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・メルファランの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Melphalan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Melphalan size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Melphalan market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Melphalan market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
2mg Tables
5mg Tables
50mg Injections
Market segment by Application, can be divided into
Multiple Myeloma
Ovarian Cancer
AL Amyloidosis
Malignant Melanoma
Other
Market segment by players, this report covers
GlaxoSmithKline
Celon Laboratories
Natco Pharma
Emcure Pharmaceuticals
GLS Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Melphalan
1.2 Classification of Melphalan by Type
1.2.1 Overview: Global Melphalan Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Melphalan Revenue Market Share by Type in 2020
1.2.3 2mg Tables
1.2.4 5mg Tables
1.2.5 50mg Injections
1.3 Global Melphalan Market by Application
1.3.1 Overview: Global Melphalan Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Multiple Myeloma
1.3.3 Ovarian Cancer
1.3.4 AL Amyloidosis
1.3.5 Malignant Melanoma
1.3.6 Other
1.4 Global Melphalan Market Size & Forecast
1.5 Global Melphalan Market Size and Forecast by Region
1.5.1 Global Melphalan Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Melphalan Market Size by Region, (2016-2021)
1.5.3 North America Melphalan Market Size and Prospect (2016-2026)
1.5.4 Europe Melphalan Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Melphalan Market Size and Prospect (2016-2026)
1.5.6 South America Melphalan Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Melphalan Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Melphalan Market Drivers
1.6.2 Melphalan Market Restraints
1.6.3 Melphalan Trends Analysis
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Melphalan Product and Solutions
2.1.4 GlaxoSmithKline Melphalan Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GlaxoSmithKline Recent Developments and Future Plans
2.2 Celon Laboratories
2.2.1 Celon Laboratories Details
2.2.2 Celon Laboratories Major Business
2.2.3 Celon Laboratories Melphalan Product and Solutions
2.2.4 Celon Laboratories Melphalan Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Celon Laboratories Recent Developments and Future Plans
2.3 Natco Pharma
2.3.1 Natco Pharma Details
2.3.2 Natco Pharma Major Business
2.3.3 Natco Pharma Melphalan Product and Solutions
2.3.4 Natco Pharma Melphalan Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Natco Pharma Recent Developments and Future Plans
2.4 Emcure Pharmaceuticals
2.4.1 Emcure Pharmaceuticals Details
2.4.2 Emcure Pharmaceuticals Major Business
2.4.3 Emcure Pharmaceuticals Melphalan Product and Solutions
2.4.4 Emcure Pharmaceuticals Melphalan Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Emcure Pharmaceuticals Recent Developments and Future Plans
2.5 GLS Pharma
2.5.1 GLS Pharma Details
2.5.2 GLS Pharma Major Business
2.5.3 GLS Pharma Melphalan Product and Solutions
2.5.4 GLS Pharma Melphalan Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GLS Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Melphalan Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Melphalan Players Market Share
3.2.2 Top 10 Melphalan Players Market Share
3.2.3 Market Competition Trend
3.3 Melphalan Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Melphalan Revenue and Market Share by Type (2016-2021)
4.2 Global Melphalan Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Melphalan Revenue Market Share by Application (2016-2021)
5.2 Melphalan Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Melphalan Revenue by Type (2016-2026)
6.2 North America Melphalan Revenue by Application (2016-2026)
6.3 North America Melphalan Market Size by Country
6.3.1 North America Melphalan Revenue by Country (2016-2026)
6.3.2 United States Melphalan Market Size and Forecast (2016-2026)
6.3.3 Canada Melphalan Market Size and Forecast (2016-2026)
6.3.4 Mexico Melphalan Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Melphalan Revenue by Type (2016-2026)
7.2 Europe Melphalan Revenue by Application (2016-2026)
7.3 Europe Melphalan Market Size by Country
7.3.1 Europe Melphalan Revenue by Country (2016-2026)
7.3.2 Germany Melphalan Market Size and Forecast (2016-2026)
7.3.3 France Melphalan Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Melphalan Market Size and Forecast (2016-2026)
7.3.5 Russia Melphalan Market Size and Forecast (2016-2026)
7.3.6 Italy Melphalan Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Melphalan Revenue by Type (2016-2026)
8.2 Asia-Pacific Melphalan Revenue by Application (2016-2026)
8.3 Asia-Pacific Melphalan Market Size by Region
8.3.1 Asia-Pacific Melphalan Revenue by Region (2016-2026)
8.3.2 China Melphalan Market Size and Forecast (2016-2026)
8.3.3 Japan Melphalan Market Size and Forecast (2016-2026)
8.3.4 South Korea Melphalan Market Size and Forecast (2016-2026)
8.3.5 India Melphalan Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Melphalan Market Size and Forecast (2016-2026)
8.3.7 Australia Melphalan Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Melphalan Revenue by Type (2016-2026)
9.2 South America Melphalan Revenue by Application (2016-2026)
9.3 South America Melphalan Market Size by Country
9.3.1 South America Melphalan Revenue by Country (2016-2026)
9.3.2 Brazil Melphalan Market Size and Forecast (2016-2026)
9.3.3 Argentina Melphalan Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Melphalan Revenue by Type (2016-2026)
10.2 Middle East & Africa Melphalan Revenue by Application (2016-2026)
10.3 Middle East & Africa Melphalan Market Size by Country
10.3.1 Middle East & Africa Melphalan Revenue by Country (2016-2026)
10.3.2 Turkey Melphalan Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Melphalan Market Size and Forecast (2016-2026)
10.3.4 UAE Melphalan Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Melphalan Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Melphalan Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Melphalan Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Melphalan Revenue (USD Million) by Region (2016-2021)
Table 5. Global Melphalan Revenue Market Share by Region (2021-2026)
Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 7. GlaxoSmithKline Major Business
Table 8. GlaxoSmithKline Melphalan Product and Solutions
Table 9. GlaxoSmithKline Melphalan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Celon Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Celon Laboratories Major Business
Table 12. Celon Laboratories Melphalan Product and Solutions
Table 13. Celon Laboratories Melphalan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Natco Pharma Corporate Information, Head Office, and Major Competitors
Table 15. Natco Pharma Major Business
Table 16. Natco Pharma Melphalan Product and Solutions
Table 17. Natco Pharma Melphalan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Emcure Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Emcure Pharmaceuticals Major Business
Table 20. Emcure Pharmaceuticals Melphalan Product and Solutions
Table 21. Emcure Pharmaceuticals Melphalan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GLS Pharma Corporate Information, Head Office, and Major Competitors
Table 23. GLS Pharma Major Business
Table 24. GLS Pharma Melphalan Product and Solutions
Table 25. GLS Pharma Melphalan Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Melphalan Revenue (USD Million) by Players (2019-2021)
Table 27. Global Melphalan Revenue Share by Players (2019-2021)
Table 28. Breakdown of Melphalan by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Melphalan Players Head Office, Products and Services Provided
Table 30. Melphalan Mergers & Acquisitions in the Past Five Years
Table 31. Melphalan New Entrants and Expansion Plans
Table 32. Global Melphalan Revenue (USD Million) by Type (2016-2021)
Table 33. Global Melphalan Revenue Share by Type (2016-2021)
Table 34. Global Melphalan Revenue Forecast by Type (2021-2026)
Table 35. Global Melphalan Revenue by Application (2016-2021)
Table 36. Global Melphalan Revenue Forecast by Application (2021-2026)
Table 37. North America Melphalan Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Melphalan Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Melphalan Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Melphalan Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Melphalan Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Melphalan Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Melphalan Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Melphalan Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Melphalan Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Melphalan Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Melphalan Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Melphalan Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Melphalan Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Melphalan Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Melphalan Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Melphalan Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Melphalan Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Melphalan Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Melphalan Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Melphalan Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Melphalan Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Melphalan Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Melphalan Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Melphalan Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Melphalan Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Melphalan Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Melphalan Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Melphalan Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Melphalan Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Melphalan Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Melphalan Picture
Figure 2. Global Melphalan Revenue Market Share by Type in 2020
Figure 3. 2mg Tables
Figure 4. 5mg Tables
Figure 5. 50mg Injections
Figure 6. Melphalan Revenue Market Share by Application in 2020
Figure 7. Multiple Myeloma Picture
Figure 8. Ovarian Cancer Picture
Figure 9. AL Amyloidosis Picture
Figure 10. Malignant Melanoma Picture
Figure 11. Other Picture
Figure 12. Global Melphalan Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Melphalan Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Melphalan Revenue Market Share by Region (2016-2026)
Figure 15. Global Melphalan Revenue Market Share by Region in 2020
Figure 16. North America Melphalan Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Melphalan Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Melphalan Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Melphalan Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Melphalan Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Melphalan Market Drivers
Figure 22. Melphalan Market Restraints
Figure 23. Melphalan Market Trends
Figure 24. GlaxoSmithKline Recent Developments and Future Plans
Figure 25. Celon Laboratories Recent Developments and Future Plans
Figure 26. Natco Pharma Recent Developments and Future Plans
Figure 27. Emcure Pharmaceuticals Recent Developments and Future Plans
Figure 28. GLS Pharma Recent Developments and Future Plans
Figure 29. Global Melphalan Revenue Share by Players in 2020
Figure 30. Melphalan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Melphalan Revenue Market Share in 2020
Figure 32. Global Top 10 Players Melphalan Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Melphalan Revenue Share by Type in 2020
Figure 35. Global Melphalan Market Share Forecast by Type (2021-2026)
Figure 36. Global Melphalan Revenue Share by Application in 2020
Figure 37. Global Melphalan Market Share Forecast by Application (2021-2026)
Figure 38. North America Melphalan Sales Market Share by Type (2016-2026)
Figure 39. North America Melphalan Sales Market Share by Application (2016-2026)
Figure 40. North America Melphalan Revenue Market Share by Country (2016-2026)
Figure 41. United States Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Melphalan Sales Market Share by Type (2016-2026)
Figure 45. Europe Melphalan Sales Market Share by Application (2016-2026)
Figure 46. Europe Melphalan Revenue Market Share by Country (2016-2026)
Figure 47. Germany Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Melphalan Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Melphalan Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Melphalan Revenue Market Share by Region (2016-2026)
Figure 55. China Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Melphalan Sales Market Share by Type (2016-2026)
Figure 62. South America Melphalan Sales Market Share by Application (2016-2026)
Figure 63. South America Melphalan Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Melphalan Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Melphalan Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Melphalan Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Melphalan Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
世界の多発性骨髄腫用従来型化学療法薬市場 2021：企業別、地域別、種類・用途別 The Traditional Chemotherapy Drugs for Multiple Myeloma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…- 世界の多発性骨髄腫用モノクローナル抗体市場 2021：企業別、地域別、種類・用途別 The Monoclonal Antibody for Multiple Myeloma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界の上皮性卵巣がん治療市場 2021：企業別、地域別、種類・用途別 The Epithelial Ovarian Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界のプレリキサフォル市場 2021：企業別、地域別、種類・用途別 The Plerixafor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …
- 世界の血液がん用遺伝子改変免疫療法市場 2021：企業別、地域別、種類・用途別 The Gene Modifying Immunotherapy for Blood Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…